Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
Kennedy Jr.'s installation atop the nation’s health bureaucracy. The Advisory Committee on Immunization Practices (ACIP) ...
The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...
The Advisory Committee on Immunization Practices (ACIP) meeting will be postponed to allow public comment prior to the ...
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback